Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |